Altimmune (ALT) had the highest return between February 1, 2017 and February 28, 2018 by a US stock, returning 1,247,268.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Altimmune (ALT) | 2/1/2017 - 2/28/2018 | 1,247,268.42% |
SurgePays (SURG) | 2/1/2017 - 2/28/2018 | 730,669.23% |
Quantum Computing (QUBT) | 2/1/2017 - 2/28/2018 | 11,900% |
FingerMotion (FNGR) | 2/1/2017 - 2/28/2018 | 11,300% |
GT Biopharma (GTBP) | 2/1/2017 - 2/28/2018 | 4,650% |
Delcath Systems (DCTH) | 2/1/2017 - 2/28/2018 | 2,951.66% |
GrabAGun Digital (PEW) | 2/1/2017 - 2/28/2018 | 2,326.47% |
HIVE Digital Technologies (HIVE) | 2/1/2017 - 2/28/2018 | 1,687.5% |
Galaxy Digital (GLXY) | 2/1/2017 - 2/28/2018 | 1,479% |
Lexinfintech (LX) | 2/1/2017 - 2/28/2018 | 1,155.85% |
Datasea (DTSS) | 2/1/2017 - 2/28/2018 | 1,120% |
TSS, Inc Common Stock (TSSI) | 2/1/2017 - 2/28/2018 | 1,075% |
Precipio (PRPO) | 2/1/2017 - 2/28/2018 | 814.38% |
Madrigal Pharmaceuticals (MDGL) | 2/1/2017 - 2/28/2018 | 722.72% |
MDxHealth SA ADR (MDXH) | 2/1/2017 - 2/28/2018 | 633.33% |
Nektar Therapeutics (NKTR) | 2/1/2017 - 2/28/2018 | 614.19% |
AnaptysBio (ANAB) | 2/1/2017 - 2/28/2018 | 611.24% |
Cronos (CRON) | 2/1/2017 - 2/28/2018 | 589.68% |
Esperion Therapeutics (ESPR) | 2/1/2017 - 2/28/2018 | 556.94% |
Neuroone Medical Technologies (NMTC) | 2/1/2017 - 2/28/2018 | 535.29% |
Netcapital (NCPL) | 2/1/2017 - 2/28/2018 | 500% |
XOMA Royalty (XOMA) | 2/1/2017 - 2/28/2018 | 496.44% |
Orion Digital (ORIO) | 2/1/2017 - 2/28/2018 | 491.15% |
Avalo Therapeutics (AVTX) | 2/1/2017 - 2/28/2018 | 481.77% |
CareCloud (CCLD) | 2/1/2017 - 2/28/2018 | 435.14% |